Nezeril Nefúði, lausn 0,25 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

nezeril nefúði, lausn 0,25 mg/ml

perrigo sverige ab - oxymetazolinum hýdróklóríð - nefúði, lausn - 0,25 mg/ml

Nezeril Nefúði, lausn 0,5 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

nezeril nefúði, lausn 0,5 mg/ml

perrigo sverige ab - oxymetazolinum hýdróklóríð - nefúði, lausn - 0,5 mg/ml

Pombiliti Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Opfolda Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

opfolda

amicus therapeutics europe limited - miglustat - glycogen geymsluskammt tegund ii - Önnur meltingarfæri og umbrotsefni - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).